A different study on expression patterns has identified an overexpression of IL-10 in IL-10 positive B cells derived from patients with diagnosed SLE and its regulatory loop E2F2-miR-17-5p which authors suggested as a potential treatment target [91]. The gene discussed is IL10; the disease is systemic lupus erythematosus.